A transaction struck last year by Evercare Group, an emerging markets healthcare platform managed by private equity firm TPG’s impact investment unit The Rise Fund, to sell its stake in a South Asian asset has come unstuck. The deal, pegged around $72.35 million, involved Actis-backed Egyptian company Integrated Diagnostics Holdings […]
This post is only available to members.